Clinical Trial Update: A Study of Xiongdan Wan Treating Depression [Phase 2]

View source ↗

Summary

Phase 2 clinical trial completed examining Xiongdan Wan for major depressive disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Xiongdan Wan

Snippet

Sponsor: Shanghai Mental Health Center | Conditions: Major Depressive Disorder | Phase 2 | Status: COMPLETED